The expression of TP53I13 was detected in various cancer types such as glioblastoma tissues (Figure 2A), cholangiocarcinoma (CHOL), lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), Kidney renal clear cell carcinoma (KIRC), skin cutaneous melanoma (SKCM), low-grade glioma (LGG), bladder urothelial carcinoma (BLCA), and thymoma (THYM). This evidence concerns the gene TP53I13 and cholangiocarcinoma.